Apparently you are having trouble interpreting these results. So let's take a closer look. I have expanded your emphasis, you missed some key facts.
The full abstracts for Skeptigirl's evidence for the effectiveness of the seasonal flu vaccine:
http://www.ncbi.nlm.nih.gov/sites/en...RVAbstractPlus
BACKGROUND: The effectiveness of influenza vaccination against hospitalization and death can only ethically be assessed in observational studies. A concern is that individuals who are vaccinated are healthier than individuals who are not vaccinated, potentially biasing estimates of effectiveness upward. METHODS: We conducted a historical cohort study of individuals >64 years of age, for whom there were data available in the General Practice Research Database for 1989 to 1999 in England and Wales. Rates of admissions for acute respiratory diseases and rates of death due to respiratory disease were compared over 692,819 person-years in vaccine recipients and 1,534,280 person-years in vaccine nonrecipients. RESULTS: The pooled effectiveness of vaccine against hospitalizations for acute respiratory disease was 21% (95% confidence interval [CI], 17%-26%). The rate reduction attributable to vaccination was 4.15 hospitalizations/100,000 person-weeks in the influenza season. Among vaccine recipients, no important reduction in the number of admissions to the hospital was seen outside influenza seasons. The pooled effectiveness of vaccine against deaths due to respiratory disease was 12% (95% CI, 8%-16%). A greater proportionate reduction was seen among people without medical disorders, but absolute rate reduction was higher in individuals with medical disorders, compared with individuals without such disorders (6.14 deaths due to respiratory disease/100,000 person-weeks vs. 3.12 deaths due to respiratory disease/100,000 person-weeks). Clear protection against death due to all causes was not seen. CONCLUSIONS: Influenza vaccination reduces the number of hospitalizations and deaths due to respiratory disease, after correction for confounding in individuals >64 years of age who had a high risk or a low risk for influenza. For elderly people, untargeted influenza vaccination is of confirmed benefit against serious outcomes.
Vaccine recipients had equal outcomes when there was no flu around. That contradicts the single study which found no difference between vaccine recipients in or out of flu season. The contradicted study suggested the reason for less morbidity and mortality in the vaccine group was that healthier people chose to be vaccinated. This is a bit counter-intuitive since providers encourage less healthy people to get vaccinated and there is evidence people do follow their provider's advice. This study contradicts that finding and suggests the vaccine benefit shows up during flu season as you would expect.
This study also shows both healthy and less healthy people see a reduction in hospitalization and death when vaccinated.
You also seem to think the number here, 12% represents the effectiveness against the flu. Not so, it is the reduction in deaths in all respiratory infections. The reason for using this calculation is because it is not practical nor necessary to culture the organism in every pneumonia death. One assumes if deaths are lower among vaccine recipients when flu is prevalent, and the same when flu is not prevalent that the vaccine is preventing flu deaths.
You also claim this is a minor benefit. With 35,000 annual deaths from influenza, 12% more would be dying without the use of the vaccine. Annual flu vaccine would be preventing about 4,500 deaths if my rapid math estimate is correct. So again, your claim the cost of the vaccine is not worth benefit is simply warped.
http://www.ncbi.nlm.nih.gov/sites/en...ubmed_RVDocSum
BACKGROUND: Reliable estimates of the effectiveness of influenza vaccine among persons 65 years of age and older are important for informed vaccination policies and programs. Short-term studies may provide misleading pictures of long-term benefits, and residual confounding may have biased past results. This study examined the effectiveness of influenza vaccine in seniors over the long term while addressing potential bias and residual confounding in the results. METHODS: Data were pooled from 18 cohorts of community-dwelling elderly members of one U.S. health maintenance organization (HMO) for 1990-1991 through 1999-2000 and of two other HMOs for 1996-1997 through 1999-2000. Logistic regression was used to estimate the effectiveness of the vaccine for the prevention of hospitalization for pneumonia or influenza and death after adjustment for important covariates. Additional analyses explored for evidence of bias and the potential effect of residual confounding. RESULTS: There were 713,872 person-seasons of observation. Most high-risk medical conditions that were measured were more prevalent among vaccinated than among unvaccinated persons. Vaccination was associated with a 27% reduction in the risk of hospitalization for pneumonia or influenza (adjusted odds ratio, 0.73; 95% confidence interval [CI], 0.68 to 0.77) and a 48% reduction in the risk of death (adjusted odds ratio, 0.52; 95% CI, 0.50 to 0.55). Estimates were generally stable across age and risk subgroups. In the sensitivity analyses, we modeled the effect of a hypothetical unmeasured confounder that would have caused overestimation of vaccine effectiveness in the main analysis; vaccination was still associated with statistically significant--though lower--reductions in the risks of both hospitalization and death. CONCLUSIONS: During 10 seasons, influenza vaccination was associated with significant reductions in the risk of hospitalization for pneumonia or influenza and in the risk of death among community-dwelling elderly persons. Vaccine delivery to this high-priority group should be improved. Copyright 2007 Massachusetts Medical Society.
So both studies confirm exactly what I said in my previous post, which was that the flu shot varies in effectiveness from poor to good and doesn't stop many people being admitted to hospital or dying.
Where do you get this "poor effectiveness" here? Again, you don't even know what you are looking at. There are many causes of pneumonia. The influenza vaccine is not going to protect people against all pneumonia. That's ignorant. Studies report decreases in total pneumonia cases like I said, because we calculate rates based on sampling, not based on culturing each infective organism in each patient.
This study gives some idea of what is going on in the second study, which appears to show a significant reduction in risk of death:
Quote:
BACKGROUND: Numerous observational studies have reported that seniors who receive influenza vaccine are at substantially lower risk of death and hospitalization during the influenza season than unvaccinated seniors. These estimates could be influenced by differences in underlying health status between the vaccinated and unvaccinated groups. Since a protective effect of vaccination should be specific to influenza season, evaluation of non-influenza periods could indicate the possible contribution of bias to the estimates observed during influenza season. METHODS: We evaluated a cohort of 72,527 persons 65 years of age and older followed during an 8 year period and assessed the risk of death from any cause, or hospitalization for pneumonia or influenza, in relation to influenza vaccination, in periods before, during, and after influenza seasons. Secondary models adjusted for covariates defined primarily by diagnosis codes assigned to medical encounters. RESULTS: The relative risk of death for vaccinated persons compared with unvaccinated persons was 0.39 [95% confidence interval (95% CI), 0.33-0.47] before influenza season, 0.56 (0.52-0.61) during influenza season, and 0.74 (0.67-0.80) after influenza season. The relative risk of pneumonia hospitalization was 0.72 (0.59-0.89) before, 0.82 (0.75-0.89) during, and 0.95 (0.85-1.07) after influenza season. Adjustment for diagnosis code variables resulted in estimates that were further from the null, in all time periods. CONCLUSIONS: The reductions in risk before influenza season indicate preferential receipt of vaccine by relatively healthy seniors. Adjustment for diagnosis code variables did not control for this bias. In this study, the magnitude of the bias demonstrated by the associations before the influenza season was sufficient to account entirely for the associations observed during influenza season.
Right, Ivor, take one study, despite the fact the other two have different outcomes and proclaim it is the correct outcome. I posted this study for a reason. I did so because I was consciously not trying to cherry pick the data. You, however, don't seem to have the same objective view. Why am I not surprised?